As disruption of Ran expression and function is linked to most cancers, including NSCLC (112, 113), this data suggest that the impact of RBP expression changes on Ran pathway may contribute to increased risk of cancer development in a subset of COPD patients. The gene discussed is RAN; the disease is cancer.